Cytosorbents (CTSO) Return on Invested Capital (QoQ) (2017 - 2024)
Cytosorbents (CTSO) Return on Invested Capital (QoQ) (2017 - 2024) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.10 Bn | 98.88 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.99 Bn | 66.53 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.15 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 23.74 Bn | 20.62 Bn | 2.07 Bn |
| 10 | Cytosorbents | 22.27 Mn | 17.47 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.00 |
| Mar 31, 2024 | 8.00 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.00 |
| Sep 30, 2020 | 1.00 |
| Jun 30, 2020 | 1.00 |
| Mar 31, 2020 | 1.00 |
| Dec 31, 2019 | 1.00 |
| Sep 30, 2019 | 2.00 |
| Jun 30, 2019 | 5.00 |
| Mar 31, 2019 | -4.00 |
| Dec 31, 2018 | -4.00 |
| Sep 30, 2018 | -1.00 |
| Jun 30, 2018 | 0.00 |
| Mar 31, 2018 | 0.00 |
| Dec 31, 2017 | 1.00 |
| Sep 30, 2017 | 1.00 |
| Jun 30, 2017 | 3.00 |
| Mar 31, 2017 | 8.00 |